Skip to content

Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia Laciniosa) churna in the manegement of PCOS

Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia laciniosa) churna in the manegement of PCOS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094375
Enrollment
140
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

Dr D Y Patil College of Ayurved Hospital Pimpari Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married Unmarried Both. PCOS diagnosed by Rotterdam crieteria 2/3

Exclusion criteria

Exclusion criteria: Patients showing signs and symptoms other than PCOS Patients having any other disease causing Oligomenorrhea and Anovulation excluding PCOS on above criteria i.e. Hypogonadotrophic Hypogonadism, Premature Ovarian Failure. 4. Patients suffering from a) Congenital Adrenal Hyperplasia b) Severe Insulin resistance (Insulin dependent Diabetes Mellitus) c) Androgen secreting Ovarian and Adrenal tumors d) Thyroid abnormalities e) Cushing?s syndrome f) Cardiac disease g) Hyperprolactemia. Patients with any organic lesions of Reproductive Tract like TB, Ca, Congenital anomalies, any other pelvic pathologies. A current or previous (within 3 months) use of OC Pills, Glucocorticoids, Antiandrogens, Antidiabetics, Antiobesity drugs or any Hormonal Therapy.

Design outcomes

Primary

MeasureTime frame
Regularisation of menstrual cycleTimepoint: Regularisation of menstrual cycle after 90 days

Secondary

MeasureTime frame
effect of Shivlingi beeja churna on Insulin resistanceTimepoint: Sr Inshulin levels;Change in BMITimepoint: BMI calculated

Countries

India

Contacts

Public ContactVD PRASHANT DALVI

Associate Professor, R. A. Podar Medical College AYU,

drdalvipn@gmail.com9822783636

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026